BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 8064812)

  • 1. The impact of population based screening for carriers of cystic fibrosis.
    Bekker H; Denniss G; Modell M; Bobrow M; Marteau T
    J Med Genet; 1994 May; 31(5):364-8. PubMed ID: 8064812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychological impact of population-based carrier testing for cystic fibrosis: 3-year follow-up. UK Cystic Fibrosis Follow-Up Study Group.
    Axworthy D; Brock DJ; Bobrow M; Marteau TM
    Lancet; 1996 May; 347(9013):1443-6. PubMed ID: 8676627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of cystic fibrosis testing in primary care: supply push or demand pull?
    Bekker H; Modell M; Denniss G; Silver A; Mathew C; Bobrow M; Marteau T
    BMJ; 1993 Jun; 306(6892):1584-6. PubMed ID: 8329922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise v couple screening.
    Miedzybrodzka ZH; Hall MH; Mollison J; Templeton A; Russell IT; Dean JC; Kelly KF; Marteau TM; Haites NE
    BMJ; 1995 Feb; 310(6976):353-7. PubMed ID: 7866213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal screening for cystic fibrosis: psychological effects on carriers and their partners.
    Mennie ME; Compton ME; Gilfillan A; Liston WA; Pullen I; Whyte DA; Brock DJ
    J Med Genet; 1993 Jul; 30(7):543-8. PubMed ID: 8411025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A preliminary trial of couple screening for cystic fibrosis: designing an appropriate information leaflet.
    Livingstone J; Axton RA; Mennie M; Gilfillan A; Brock DJ
    Clin Genet; 1993 Feb; 43(2):57-62. PubMed ID: 8448901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The uptake and acceptability to patients of cystic fibrosis carrier testing offered in pregnancy by the GP.
    Hartley NE; Scotcher D; Harris H; Williamson P; Wallace A; Craufurd D; Harris R
    J Med Genet; 1997 Jun; 34(6):459-64. PubMed ID: 9192264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic fibrosis carrier population screening in the primary care setting.
    Loader S; Caldwell P; Kozyra A; Levenkron JC; Boehm CD; Kazazian HH; Rowley PT
    Am J Hum Genet; 1996 Jul; 59(1):234-47. PubMed ID: 8659530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-population screening for carriers of cystic fibrosis gene.
    Carswell F
    Lancet; 1996 May; 347(9013):1421-2. PubMed ID: 8676620
    [No Abstract]   [Full Text] [Related]  

  • 10. Patient and parental attitudes toward genetic screening and its implications at an adult cystic fibrosis centre.
    Conway SP; Allenby K; Pond MN
    Clin Genet; 1994 Jun; 45(6):308-12. PubMed ID: 7923862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychological and social consequences of community carrier screening programme for cystic fibrosis.
    Watson EK; Mayall ES; Lamb J; Chapple J; Williamson R
    Lancet; 1992 Jul; 340(8813):217-20. PubMed ID: 1353144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carrier screening for cystic fibrosis in a prenatal setting.
    Delvaux I; van Tongerloo A; Messiaen L; Van Loon C; De Bie S; Mortier G; De Paepe A
    Genet Test; 2001; 5(2):117-25. PubMed ID: 11551097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic fibrosis carrier testing in early pregnancy by general practitioners.
    Harris H; Scotcher D; Hartley N; Wallace A; Craufurd D; Harris R
    BMJ; 1993 Jun; 306(6892):1580-3. PubMed ID: 8329921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal screening for cystic fibrosis carriers: does the method of testing affect the longer-term understanding and reproductive behaviour of women?
    Mennie ME; Axworthy D; Liston WA; Brock DJ
    Prenat Diagn; 1997 Sep; 17(9):853-60. PubMed ID: 9316130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population screening for cystic fibrosis: knowledge and emotional consequences 18 months later.
    Gordon C; Walpole I; Zubrick SR; Bower C
    Am J Med Genet A; 2003 Jul; 120A(2):199-208. PubMed ID: 12833400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystic fibrosis heterozygote screening in 5,161 pregnant women.
    Witt DR; Schaefer C; Hallam P; Wi S; Blumberg B; Fishbach A; Holtzman J; Kornfeld S; Lee R; Nemzer L; Palmer R
    Am J Hum Genet; 1996 Apr; 58(4):823-35. PubMed ID: 8644747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for carriers of cystic fibrosis--a general practitioner's perspective.
    Modell M
    BMJ; 1993 Oct; 307(6908):849-52. PubMed ID: 8401130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A follow-up study of carriers of cystic fibrosis].
    Brandt NJ; Schwartz M; Skovby F; Clausen H
    Ugeskr Laeger; 1996 Aug; 158(33):4623-7. PubMed ID: 8760517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of interest by nonpregnant couples in population-based cystic fibrosis carrier screening.
    Clayton EW; Hannig VL; Pfotenhauer JP; Parker RA; Campbell PW; Phillips JA
    Am J Hum Genet; 1996 Mar; 58(3):617-27. PubMed ID: 8644721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability of carrier screening for cystic fibrosis during pregnancy in a German population.
    Jung U; Urner U; Grade K; Coutelle C
    Hum Genet; 1994 Jul; 94(1):19-24. PubMed ID: 8034290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.